High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.

作者: Benedikt Fischer , Wayne Jones , Jürgen Rehm

DOI: 10.1002/PDS.3404

关键词: MedicineMortality rateDemographyGerontologyPopulationHydromorphoneStandardized rateContext (language use)OxycodonePharmacoepidemiologyPopulation health

摘要: Purpose Prescription opioid analgesic (POA)-related burden of disease – including mortality is high and constitutes a major public health problem in the US Canada. Associations between overall levels POA consumption key related morbidity indicators population have been demonstrated. We examined potential correlations four commonly used POAs British Columbia (BC) Ontario. Methods We investigated correlation annual standardized rates fentanyl, hydromorphone, morphine oxycodone-related (based on provincial coroners' data) Defined Daily Doses per 1000 population/day for each drugs dispensed representative retail pharmacy sales two provinces, 2005-2009. Results Death increased three (Ontario) drugs; rate deaths drug was consistently higher jurisdiction with use levels. For drug, strong (range 0.83 to 0.97; p < 0.003) were found levels; consistent within-province (hydromorphone oxycodone). Conclusions Our findings select reflect similar evidence from elsewhere or indicators. In context increasing Canada, efforts reduce POA-related may require comprehensively revised approach towards more appropriate safer prescribing volumes together effective monitoring medications. Copyright © 2013 John Wiley & Sons, Ltd.

参考文章(11)
Leonard J. Paulozzi, Rose A. Rudd, Karin A. Mack, Christopher M. Jones, Vital Signs: Overdoses of Prescription Opioid Pain Relievers - United States, 1999-2008 Morbidity and Mortality Weekly. ,vol. 60, pp. 1487- ,(2011)
Leonard J. Paulozzi, Edwin M. Kilbourne, Hema A. Desai, Prescription Drug Monitoring Programs and Death Rates from Drug Overdose Pain Medicine. ,vol. 12, pp. 747- 754 ,(2011) , 10.1111/J.1526-4637.2011.01062.X
Angela M. Wisniewski, Christopher H. Purdy, Richard D. Blondell, The Epidemiologic Association Between Opioid Prescribing, Non-Medical Use, and Emergency Department Visits Journal of Addictive Diseases. ,vol. 27, pp. 1- 11 ,(2008) , 10.1300/J069V27N01_01
Benedikt Fischer, Wayne Jones, Murray Krahn, Jürgen Rehm, Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiology and Drug Safety. ,vol. 20, pp. 1269- 1277 ,(2011) , 10.1002/PDS.2190
Thor Norström, Thor Norström, Mats Ramstedt, Thor Norström, Mats Ramstedt, Mortality and population drinking: a review of the literature. Drug and Alcohol Review. ,vol. 24, pp. 537- 547 ,(2005) , 10.1080/09595230500293845
Tara Gomes, David Juurlink, Rahim Moineddin, Piotr Gozdyra, Irfan Dhalla, Michael Paterson, Muhammad Mamdani, Geographical Variation in Opioid Prescribing and Opioid-Related Mortality in Ontario Healthcare quarterly (Toronto). ,vol. 14, pp. 22- 24 ,(2011) , 10.12927/HCQ.2011.22153
A. C. Rintoul, M. D. H. Dobbin, O. H. Drummer, J. Ozanne-Smith, Increasing deaths involving oxycodone, Victoria, Australia, 2000–09 Injury Prevention. ,vol. 17, pp. 254- 259 ,(2011) , 10.1136/IP.2010.029611
Gary M. Franklin, Jaymie Mai, Judith Turner, Mark Sullivan, Thomas Wickizer, Deborah Fulton-Kehoe, Bending the Prescription Opioid Dosing and Mortality Curves: Impact of the Washington State Opioid Dosing Guideline American Journal of Industrial Medicine. ,vol. 55, pp. 325- 331 ,(2012) , 10.1002/AJIM.21998
I. A. Dhalla, M. M. Mamdani, M. L.A. Sivilotti, A. Kopp, O. Qureshi, D. N. Juurlink, Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone Canadian Medical Association Journal. ,vol. 181, pp. 891- 896 ,(2009) , 10.1503/CMAJ.090784